• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SLAMF6 in health and disease: Implications for therapeutic targeting.

作者信息

Yigit Burcu, Wang Ninghai, Herzog Roland W, Terhorst Cox

机构信息

Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

出版信息

Clin Immunol. 2019 Jul;204:3-13. doi: 10.1016/j.clim.2018.10.013. Epub 2018 Oct 23.

DOI:10.1016/j.clim.2018.10.013
PMID:30366106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8969216/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/199ef58a3267/nihms-1788912-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/72a1789ac242/nihms-1788912-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/f6bb483580c6/nihms-1788912-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/669f12f047bb/nihms-1788912-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/0e6e0066eb8d/nihms-1788912-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/7f6ce76d045a/nihms-1788912-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/199ef58a3267/nihms-1788912-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/72a1789ac242/nihms-1788912-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/f6bb483580c6/nihms-1788912-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/669f12f047bb/nihms-1788912-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/0e6e0066eb8d/nihms-1788912-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/7f6ce76d045a/nihms-1788912-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/8969216/199ef58a3267/nihms-1788912-f0006.jpg

相似文献

1
SLAMF6 in health and disease: Implications for therapeutic targeting.健康与疾病中的信号淋巴细胞激活分子家族6：对治疗靶点的启示
Clin Immunol. 2019 Jul;204:3-13. doi: 10.1016/j.clim.2018.10.013. Epub 2018 Oct 23.
2
SLAMF6 clustering is required to augment T cell activation.SLAMF6 聚类是增强 T 细胞激活所必需的。
PLoS One. 2019 Jun 14;14(6):e0218109. doi: 10.1371/journal.pone.0218109. eCollection 2019.
3
Slamf6 negatively regulates autoimmunity.信号淋巴细胞激活分子家族成员6（Slamf6）对自身免疫起负向调节作用。
Clin Immunol. 2016 Dec;173:19-26. doi: 10.1016/j.clim.2016.06.009. Epub 2016 Jun 29.
4
Soluble SLAMF6 Receptor Induces Strong CD8 T-cell Effector Function and Improves Anti-Melanoma Activity .可溶性 SLAMF6 受体诱导强烈的 CD8 T 细胞效应功能，并提高抗黑色素瘤活性。
Cancer Immunol Res. 2018 Feb;6(2):127-138. doi: 10.1158/2326-6066.CIR-17-0383. Epub 2018 Jan 5.
5
Expression and function of SLAMF6 in CD8 T lymphocytes of patients with severe aplastic anemia.SLAMF6 在重型再生障碍性贫血患者 CD8 T 淋巴细胞中的表达及功能。
Cell Immunol. 2021 Jun;364:104343. doi: 10.1016/j.cellimm.2021.104343. Epub 2021 Mar 15.
6
Signaling lymphocyte activation molecule family in systemic lupus erythematosus.信号淋巴细胞激活分子家族与系统性红斑狼疮。
Clin Immunol. 2019 Jul;204:57-63. doi: 10.1016/j.clim.2018.11.001. Epub 2018 Nov 8.
7
CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.CD84 细胞表面信号分子：癌症和自身免疫性疾病的新兴生物标志物和靶点。
Clin Immunol. 2019 Jul;204:43-49. doi: 10.1016/j.clim.2018.10.017. Epub 2018 Oct 26.
8
The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.CD244 信号在肿瘤微环境免疫细胞中的新兴作用。
Front Immunol. 2018 Nov 28;9:2809. doi: 10.3389/fimmu.2018.02809. eCollection 2018.
9
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells.抗SLAMF6抗体与依鲁替尼的组合可有效消除慢性淋巴细胞白血病细胞的扩增。
Oncotarget. 2016 May 3;7(18):26346-60. doi: 10.18632/oncotarget.8378.
10
Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions.抑制性免疫检查点受体 SLAMF6 的可变剪接产生显性阳性形式，增强 T 细胞效应功能。
Cancer Immunol Res. 2021 Jun;9(6):637-650. doi: 10.1158/2326-6066.CIR-20-0800. Epub 2021 Mar 24.

引用本文的文献

1
Discovery of core genes for systemic lupus erythematosus via genome-wide aggregated trans-effects analysis.通过全基因组聚集性反式效应分析发现系统性红斑狼疮的核心基因
Genes Immun. 2025 Sep 3. doi: 10.1038/s41435-025-00352-4.
2
A splice donor variant in is associated with canine atopic dermatitis.[具体基因名称]中的一个剪接受体变体与犬特应性皮炎相关。
Front Vet Sci. 2025 Jun 19;12:1550617. doi: 10.3389/fvets.2025.1550617. eCollection 2025.
3
Connection between circulating inflammatory cytokines and non-small cell lung cancer: integrated Mendelian randomization and gene function analysis.

本文引用的文献

1
SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.SLAMF1 是人类巨噬细胞 TLR4 介导的 TRAM-TRIF 依赖性信号所必需的。
J Cell Biol. 2018 Apr 2;217(4):1411-1429. doi: 10.1083/jcb.201707027. Epub 2018 Feb 12.
2
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models.在小鼠肿瘤模型中，程序性死亡受体1（PD-1）阻断增强了埃罗妥珠单抗的疗效。
Blood Adv. 2017 May 8;1(12):753-765. doi: 10.1182/bloodadvances.2017004382. eCollection 2017 May 9.
3
CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
循环炎症细胞因子与非小细胞肺癌之间的关联：孟德尔随机化与基因功能综合分析
Discov Oncol. 2025 Jun 4;16(1):1005. doi: 10.1007/s12672-025-02817-4.
4
SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria.信号淋巴细胞激活分子家族7（SLAMF7）和信号淋巴细胞激活分子家族8（SLAMF8）受体塑造了人类浆细胞样树突状细胞对细胞内细菌的反应。
J Clin Invest. 2025 Apr 15;135(8). doi: 10.1172/JCI182467.
5
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.多发性硬化症的多基因性质：基因变异、免疫调节及与环境的关联
Endocr Metab Immune Disord Drug Targets. 2024 Dec 31. doi: 10.2174/0118715303325979241206115417.
6
Endometrial regeneration cell-derived exosomes loaded with siSLAMF6 inhibit cardiac allograft rejection through the suppression of desialylation modification.负载siSLAMF6的子宫内膜再生细胞衍生外泌体通过抑制去唾液酸化修饰来抑制心脏移植排斥反应。
Cell Mol Biol Lett. 2024 Oct 1;29(1):128. doi: 10.1186/s11658-024-00645-y.
7
Bioinformatic analysis of hippocampal histopathology in Alzheimer's disease and the therapeutic effects of active components of traditional Chinese medicine.阿尔茨海默病中海马组织病理学的生物信息学分析及中药活性成分的治疗作用
Front Pharmacol. 2024 Aug 16;15:1424803. doi: 10.3389/fphar.2024.1424803. eCollection 2024.
8
Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions.改变细胞表面蛋白质的位置是调节 T 细胞功能的一种很有前途的策略。
Immunology. 2024 Oct;173(2):248-257. doi: 10.1111/imm.13828. Epub 2024 Jul 1.
9
RT-DOb, a switch gene for the gene pair {Csf1r, Milr1}, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.RT-DOb，一个基因对 {Csf1r, Milr1} 的开关基因，通过调节肥大细胞和小胶质细胞之间的通讯，可以影响阿尔茨海默病的发病。
PLoS One. 2023 Jul 6;18(7):e0288134. doi: 10.1371/journal.pone.0288134. eCollection 2023.
10
Characterization of Ly108-H1 Signaling Reveals Ly108-3 Expression and Additional Strain-Specific Differences in Lupus Prone Mice.Ly108-H1 信号特征分析揭示狼疮易感小鼠中 Ly108-3 的表达及其他株特异性差异。
Int J Mol Sci. 2023 Mar 6;24(5):5024. doi: 10.3390/ijms24055024.
CD150和CD180参与慢性淋巴细胞白血病细胞中转录因子表达的调控。
Exp Oncol. 2017 Dec;39(4):291-298.
4
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy.阿卡替尼治疗的药效学和蛋白质组学分析：与伊布替尼的靶标效应相似性及其联合治疗的原理。
Leukemia. 2018 Apr;32(4):920-930. doi: 10.1038/leu.2017.321. Epub 2017 Nov 3.
5
SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7 normal lymphocytes.SLAMF7-CAR T 细胞可消除骨髓瘤并选择性杀伤 SLAMF7 正常淋巴细胞。
Blood. 2017 Dec 28;130(26):2838-2847. doi: 10.1182/blood-2017-04-778423. Epub 2017 Oct 31.
6
The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.CD150和CD180受体途径的相互作用通过选择性抑制Akt和MAPK信号传导，对慢性淋巴细胞白血病B细胞的病理生物学产生影响。
PLoS One. 2017 Oct 5;12(10):e0185940. doi: 10.1371/journal.pone.0185940. eCollection 2017.
7
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.依鲁替尼通过 STAT3 介导的抑制调节性 B 细胞功能和抑制 PD-1/PD-L1 通路来调节 CLL 的免疫抑制微环境。
Leukemia. 2018 Apr;32(4):960-970. doi: 10.1038/leu.2017.304. Epub 2017 Oct 3.
8
Inhibition of reactive oxygen species limits expansion of chronic lymphocytic leukemia cells.抑制活性氧可限制慢性淋巴细胞白血病细胞的增殖。
Leukemia. 2017 Oct;31(10):2273-2276. doi: 10.1038/leu.2017.241. Epub 2017 Jul 28.
9
Ibrutinib treatment improves T cell number and function in CLL patients.依鲁替尼治疗可改善慢性淋巴细胞白血病（CLL）患者的T细胞数量和功能。
J Clin Invest. 2017 Aug 1;127(8):3052-3064. doi: 10.1172/JCI89756. Epub 2017 Jul 17.
10
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.人类系统性红斑狼疮的发病机制：细胞视角
Trends Mol Med. 2017 Jul;23(7):615-635. doi: 10.1016/j.molmed.2017.05.006. Epub 2017 Jun 13.